Notice type: 3rd Party Publications
Problem Or Issue:
Important Safety Information from Merck Serono (Ireland) Limited regarding Mavenclad (cladribine) – risk of serious liver injury and new recommendations about liver function monitoring
Important Safety Information – Mavenclad (cladribine)